Zonal Responsiveness of the Human Intervertebral Disc to Bone Morphogenetic Protein-2

被引:42
|
作者
Kim, Hyang [2 ,3 ]
Lee, Jeong-Uk [2 ]
Moon, Seong-Hwan [1 ]
Kim, Hyung-Chan
Kwon, Un-Hae [2 ]
Seol, Nam-Hun [2 ]
Kim, Ho-Joong
Park, Jin-Oh
Chun, Heoung-Jae [4 ]
Kwon, Il-Keun [5 ]
Lee, Hwan-Mo
机构
[1] Yonsei Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Med Sci Graduated Sch, Seoul, South Korea
[3] Inst Biomat & Med Engn, Korea Bone Bank Corp, Seoul, South Korea
[4] Yonsei Univ, Dept Mech Engn, Seoul 120749, South Korea
[5] Kyung Hee Univ, Seoul, South Korea
关键词
bone morphogenetic protein-2; intervertebral disc cell; proteoglycan synthesis; zonal effect; HUMAN OSTEOGENIC PROTEIN-1; CELLS; PROTEOGLYCANS;
D O I
10.1097/BRS.0b013e3181ae18ba
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. In vitro experiment using bone morphogenetic protein-2 (BMP-2) and cells from the nucleus pulposus (NP), transitional zone (TZ), and anulus fibrosus (AF) of the human intervertebral disc (IVD). Objective. To demonstrate the differential effect of BMP-2 on DNA synthesis, proteoglycan synthesis, and osteocalcin mRNA expression in human IVD cells from the NP, TZ, and AF, respectively. Summary of Background Data. BMP-2 has been proven to be effective in stimulating proteoglycan synthesis in articular chondrocytes and IVD cells from the NP. Nevertheless, the effect of BMP-2 on cells from different regions of the IVD has not yet been thoroughly elucidated. Methods. Human IVDs were harvested from surgical disc procedures and tissue from the NP, TZ, and AF was obtained. Disc tissue was enzymatically digested, and IVD cells were cultured three-dimensionally in alginate beads. Then IVD cell cultures from the NP, TZ, and AF were exposed to BMP-2. DNA synthesis and newly synthesized proteoglycan were measured. Reverse transcription-polymerase chain reaction for mRNA expression of bone sialoprotein, DLX5, osteocalcin, and collagen type I, was performed. Results. Cells from the AF responded to BMP-2 with mitogenesis. There was no significant increase in DNA synthesis in cultures from the NP and TZ treated with BMP-2. Only cells from the NP showed a significant increase in newly synthesized proteoglycan in response to BMP-2. IVD cells from all zones demonstrated no significant expression of bone sialoprotein, DLX5, osteocalcin mRNA after treatment with BMP-2. Conclusion. BMP-2 clearly exerted a mitogenic effect on AF cells, and stimulated proteoglycan synthesis in NP cells. However, BMP-2 did not have an osteogenic effect in any IVD region. Taken together, these results confirm that BMP-2 can be used as an anabolic agent for mitogenesis in AF cells and NP cell matrix regeneration without the possibility of osteogenesis.
引用
收藏
页码:1834 / 1838
页数:5
相关论文
共 50 条
  • [1] The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro
    Yoon, ST
    Kim, KS
    Li, J
    Park, JS
    Akamaru, T
    Elmer, WA
    Hutton, WC
    SPINE, 2003, 28 (16) : 1773 - 1780
  • [2] Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells
    Kim, DJ
    Moon, SH
    Kim, H
    Kwon, UH
    Park, MS
    Han, KJ
    Hahn, SB
    Lee, HM
    SPINE, 2003, 28 (24) : 2679 - 2684
  • [3] Bone morphogenetic protein-2 provokes interleukin-18-induced human intervertebral disc degeneration
    Ye, S.
    Ju, B.
    Wang, H.
    Lee, K-B.
    BONE & JOINT RESEARCH, 2016, 5 (09): : 412 - 418
  • [4] The in vivo biological effects of intradiscal recombinant human bone morphogenetic protein-2 on the injured intervertebral disc -: An animal experiment
    Huang, Kuo-Yuan
    Yan, Jing-Jou
    Hsieh, Chin-Chiang
    Chang, Ming-Shi
    Lin, Ruey-Mo
    SPINE, 2007, 32 (11) : 1174 - 1180
  • [5] Human chondrocyte responsiveness to bone morphogenetic protein-2 after their in vitro dedifferentiation: Potential use of bone morphogenetic protein-2 for cartilage cell therapy
    Salentey, V.
    Claus, S.
    Bougault, C.
    Paumier, A.
    Aubert-Foucher, E.
    Perrier-Groult, E.
    Ronziere, M. -C.
    Freyria, A. -M.
    Galera, P.
    Beauchef, G.
    Duterque-Coquillaud, M.
    Piperno, M.
    Damour, O.
    Herbage, B.
    Mallein-Gerin, F.
    PATHOLOGIE BIOLOGIE, 2009, 57 (04): : 282 - 289
  • [6] Covalent incorporation of bone morphogenetic protein-2 into fibrin-based hydrogels for intervertebral disc regeneration
    Karfeld-Sulzer, L. S.
    Ghayor, C.
    Weber, F. E.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2012, 6 : 41 - 41
  • [7] Recombinant human bone morphogenetic protein-2
    Shaffrey, Christopher I.
    Smith, Justin S.
    JOURNAL OF NEUROSURGERY-SPINE, 2013, 18 (02) : 109 - 110
  • [8] Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2
    Villavicencio, AT
    Burneikiene, S
    Nelson, EL
    Bulsara, KR
    Favors, M
    Thramann, J
    JOURNAL OF NEUROSURGERY-SPINE, 2005, 3 (06) : 436 - 443
  • [9] Expression of bone morphogenetic protein in the course of osteoinduction by recombinant human bone morphogenetic protein-2
    Okubo, Y
    Bessho, K
    Fujimura, K
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    CLINICAL ORAL IMPLANTS RESEARCH, 2002, 13 (01) : 80 - 85
  • [10] Recombinant human bone morphogenetic protein-2 Response
    Burkus, J. Kenneth
    JOURNAL OF NEUROSURGERY-SPINE, 2013, 18 (02) : 110 - 111